DURHAM, NC, Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing.
Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and Hevolution Foundation.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
